Related Experiment Video
Updated: Jan 23, 2026

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
New STAT3-FOXL2 pathway and its function in cancer cells
Yangyang Han1, Jun Wu2, Weiwei Yang3
1School of Bioscience and Technology, Weifang Medical University, Weifang, Shandong, 261053, People's Republic of China. hanyy2009@163.com.
Background:
The forkhead transcription factor (FOXL2) plays a crucial role in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES), sex determination, ovary growth and development, and cell cycle regulation. Emerging investigations have focused on the downstream targets of FOXL2, while little is known about its upstream regulation.
Results:
In this study, we show that FOXL2 could be regulated by STAT3 in cancer cells and that STAT3 binds to FOXL2 at the 5'- GCCTGATGTTTGTCTTCCCAGTCTGTGGCAA-3' site using EMSA and ChIP. We further found that knockdown of STAT3 or FOXL2 could significantly induce cancer cell apoptosis, indicating the importance of these two genes in cancer cell growth and apoptosis. Our data also indicated that the increased apoptotic cell rate may be caused by changes in apoptosis-related genes, such as TNF, TRAIL and GnRHR.
Conclusion:
This study presents a new upstream regulator of FOXL2 and demonstrats that this new STAT3-FOXL2 pathway has an important function in HeLaHeLa cell apoptosis, providing new insights regarding the targeting of FOXL2 for cancer prevention and treatment.
Insights
Signal transducer and activator of transcription 3 (STAT3) regulates the forkhead transcription factor (FOXL2) in cancer cells. This STAT3-FOXL2 pathway is crucial for regulating cancer cell apoptosis, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The forkhead transcription factor (FOXL2) is vital for blepharophimosis-ptosis-epicanthus inversus syndrome (BPES), sex determination, ovarian development, and cell cycle control.
- While FOXL2's downstream targets are studied, its upstream regulation remains largely unknown.
Purpose of the Study:
- To investigate the upstream regulation of FOXL2.
- To explore the role of STAT3 in regulating FOXL2.
- To determine the functional significance of the STAT3-FOXL2 interaction in cancer cell apoptosis.
Main Methods:
- Electrophoretic mobility shift assay (EMSA) to confirm STAT3 binding to FOXL2.
- Chromatin immunoprecipitation (ChIP) to identify the binding site of STAT3 on FOXL2.
- Gene knockdown experiments to assess the impact of STAT3 and FOXL2 on cancer cell apoptosis.
Main Results:
- STAT3 was identified as a regulator of FOXL2 in cancer cells.
- STAT3 directly binds to the FOXL2 gene promoter at a specific DNA sequence.
- Knockdown of either STAT3 or FOXL2 significantly increased cancer cell apoptosis.
- Apoptosis induction was associated with altered expression of apoptosis-related genes like TNF, TRAIL, and GnRHR.
Conclusions:
- This study identifies STAT3 as a novel upstream regulator of FOXL2.
- The STAT3-FOXL2 pathway plays a significant role in regulating apoptosis in HeLa cells.
- These findings provide new insights for targeting FOXL2 in cancer prevention and treatment strategies.
Related Concept Videos
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Other Glycolytic Pathways
Respiration Pathways
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

